Signal Advisors Wealth LLC Has $4.59 Million Holdings in Intuitive Surgical, Inc. $ISRG

Signal Advisors Wealth LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.1% in the fourth quarter, HoldingsChannel reports. The firm owned 8,112 shares of the medical equipment provider’s stock after purchasing an additional 1,415 shares during the period. Signal Advisors Wealth LLC’s holdings in Intuitive Surgical were worth $4,594,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after buying an additional 263,828 shares during the last quarter. State Street Corp grew its stake in shares of Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after acquiring an additional 182,871 shares during the period. Capital World Investors raised its position in shares of Intuitive Surgical by 1.5% in the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after purchasing an additional 116,034 shares during the period. Norges Bank purchased a new stake in shares of Intuitive Surgical during the second quarter worth $2,569,260,000. Finally, Invesco Ltd. boosted its stake in Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after purchasing an additional 201,159 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 0.4%

Shares of NASDAQ ISRG opened at $469.98 on Thursday. The firm’s fifty day moving average is $497.60 and its 200 day moving average is $513.35. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The company has a market cap of $166.90 billion, a price-to-earnings ratio of 59.57, a PEG ratio of 3.64 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter last year, the firm earned $2.21 EPS. The company’s revenue was up 18.8% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on ISRG shares. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Royal Bank Of Canada raised their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Piper Sandler reiterated an “overweight” rating and issued a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street analysts remain broadly constructive on ISRG, with the average brokerage recommendation favoring buy/hold and continued sell‑side support that can underpin demand for the shares. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
• Positive Sentiment: Strategic expansion: ISRG is taking direct control of da Vinci and Ion distribution in Southern Europe, aiming to improve system availability, service and hospital access — a move that can drive recurring revenue and tighter customer relationships in a key geography. Intuitive Surgical Extends Southern Europe Reach As Stock Trades Below Targets
• Neutral Sentiment: Margins and tariff headwinds: Q4 margin compression was noted (margins ~37%), but management offset some pressure via cost efficiencies and strong recurring revenue — this tempers the near‑term outlook while leaving long‑term profitability intact if cost actions hold. ISRG’s Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
• Neutral Sentiment: Investor attention and stock trend pieces are increasing visibility on ISRG (more searches and “trending” writeups), which can boost liquidity but also amplify volatility as opinion pieces circulate. Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Short‑interest reporting appears inconsistent in recent feeds (large reported increases but values show zero/NaN); this data should be treated cautiously until confirmed by exchange filings. (No reliable link available.)
• Negative Sentiment: Recent share weakness: ISRG has underperformed recently (shares have moved lower vs. the market), and periodic selloffs amplify short‑term downside risk while investors wait for clearer signs that tariff and margin headwinds have stabilized. Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the transaction, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 105 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. Insiders sold 32,943 shares of company stock valued at $17,279,568 over the last three months. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.